2017-2022 United States Alzheimer's Disease Drug Market Report (Status and Outlook)

Publisher Name :
Date: 20-Nov-2017
No. of pages: 119

"This report will be delivered in 2-3 business days after the order is placed."

In 2016, the Alzheimer's Disease Drug market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

In United States market, the top players include

- Allergan

- Eisai

- Novartis

- Daiichi Sankyo

- Merz Pharma

- Pfizer

- Johnson & Johnson

- Lundbeck.

Split by product types/category, covering

- Donepezil

- Memantine

- Rivastigmine

Split by applications/end use industries, covers

- Early to Moderate Stages

- Moderate to Severe Stages

2017-2022 United States Alzheimer's Disease Drug Market Report (Status and Outlook)

Table of Contents

2017-2022 United States Alzheimer's Disease Drug Market Report (Status and Outlook)
1 Alzheimer's Disease Drug Market Overview
1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Alzheimer's Disease Drug Market Segment by Types
1.2.1 United States Alzheimer's Disease Drug Sales Present Situation and Outlook by Types (2012-2022)
1.2.2 United States Alzheimer's Disease Drug Sales Market Share by Types in 2016
1.2.3 Donepezil
1.2.3.1 Major Players of Donepezil
1.2.4 Memantine
1.2.4.1 Major Players of Memantine
1.2.5 Rivastigmine
1.2.5.1 Major Players of Rivastigmine
1.3 United States Alzheimer's Disease Drug Market Segment by Applications/End Use Industries
1.3.1 United States Alzheimer's Disease Drug Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
1.3.2 United States Alzheimer's Disease Drug Sales Market Share by Applications in 2016
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 United States Alzheimer's Disease Drug Overview and Market Size (Value) (2012-2022)
1.4.1 United States Market Alzheimer's Disease Drug Overview
1.4.2 United States Alzheimer's Disease Drug Market Size (Value and Volume) Status and Forecast (2012-2022)
2 United States Alzheimer's Disease Drug Sales, Revenue (Value) and Market Share by Players
2.1 United States Alzheimer's Disease Drug Sales and Market Share (2012-2017) by Players
2.2 United States Alzheimer's Disease Drug Revenue and Market Share by Players (2012-2017)
2.3 United States Alzheimer's Disease Drug Average Price by Players in 2016
2.4 United States Alzheimer's Disease Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Alzheimer's Disease Drug Market Competitive Situation and Trends
2.5.1 Alzheimer's Disease Drug Market Concentration Rate
2.5.2 Alzheimer's Disease Drug Market Share of Top 3 and Top 5 Players
2.5.3 Mergers & Acquisitions, Expansion
3 United States Alzheimer's Disease Drug Sales, Revenue (Value) by Type and Application (2012-2017)
3.1 United States Alzheimer's Disease Drug Sales, Revenue, Market Share and Price by Type (2012-2017)
3.1.1 United States Alzheimer's Disease Drug Sales and Market Share by Type (2012-2017)
3.1.2 United States Alzheimer's Disease Drug Revenue and Market Share by Type (2012-2017)
3.1.3 United States Alzheimer's Disease Drug Price by Type (2012-2017)
3.2 United States Alzheimer's Disease Drug Sales and Market Share by Application (2012-2017)
3.3 United States Market Alzheimer's Disease Drug Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
4 United States Alzheimer's Disease Drug Players Profiles and Sales Data
4.1 Allergan
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Allergan News
4.2 Eisai
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Eisai News
4.3 Novartis
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Novartis News
4.4 Daiichi Sankyo
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Daiichi Sankyo News
4.5 Merz Pharma
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Merz Pharma News
4.6 Pfizer
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Pfizer News
4.7 Johnson & Johnson
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Johnson & Johnson News
4.8 Lundbeck.
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Alzheimer's Disease Drug Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Lundbeck. Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Lundbeck. News
5 United States Alzheimer's Disease Drug Market Forecast (2017-2022)
5.1 United States Alzheimer's Disease Drug Sales, Revenue and Price Forecast (2017-2022)
5.1.1 United States Alzheimer's Disease Drug Sales and Growth Rate Forecast (2017-2022)
5.1.2 United States Alzheimer's Disease Drug Revenue and Growth Rate Forecast (2017-2022)
5.1.3 United States Alzheimer's Disease Drug Price Trend Forecast (2017-2022)
5.2 United States Alzheimer's Disease Drug Sales Forecast by Type (2017-2022)
5.3 United States Alzheimer's Disease Drug Sales Forecast by Application (2017-2022)
6 Production Cost Analysis of Alzheimer's Disease Drug
6.1 Main Raw Materials of Alzheimer's Disease Drug
6.1.1 List of Alzheimer's Disease Drug Main Raw Materials
6.1.2 Alzheimer's Disease Drug Main Raw Materials Price Analysis
6.1.3 Alzheimer's Disease Drug Raw Materials Major Suppliers
6.1.4 Alzheimer's Disease Drug Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Alzheimer's Disease Drug
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Alzheimer's Disease Drug Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Alzheimer's Disease Drug Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Alzheimer's Disease Drug Major Players in 2016
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Alzheimer's Disease Drug Distributors/Traders List in United States
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source

List of Tables and Figures

Figure Picture of Alzheimer's Disease Drug
Table Product Specifications of Alzheimer's Disease Drug
Figure United States Alzheimer's Disease Drug Sales (volume) for Each Type (2012-2022)
Figure United States Alzheimer's Disease Drug Sales Market Share by Types in 2016
Table Types of Alzheimer's Disease Drug
Figure Product Picture of Donepezil
Table Major Players of Donepezil
Figure Product Picture of Memantine
Table Major Players of Memantine
Figure Product Picture of Rivastigmine
Table Major Players of Rivastigmine
Figure United States Alzheimer's Disease Drug Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Alzheimer's Disease Drug Sales Market Share by Applications in 2016
Table Applications of Alzheimer's Disease Drug
Figure Early to Moderate Stages Examples
Figure Moderate to Severe Stages Examples
Figure United States Alzheimer's Disease Drug Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Alzheimer's Disease Drug Sales (Volume) Status and Forecast (2012-2022)
Table United States Alzheimer's Disease Drug Sales by Players (2012-2017)
Table United States Alzheimer's Disease Drug Sales Market Share (%) by Players (2012-2017)
Figure United States Alzheimer's Disease Drug Sales Share by Players in 2016
Figure United States Alzheimer's Disease Drug Sales Share by Players in 2017
Table United States Alzheimer's Disease Drug Revenue (Million USD) by Players (2012-2017)
Table United States Alzheimer's Disease Drug Revenue Market Share (%) by Players (2012-2017)
Figure United States Alzheimer's Disease Drug Revenue Share by Players in 2016
Figure United States Alzheimer's Disease Drug Revenue Share by Players in 2017
Figure United States Alzheimer's Disease Drug Average Price by Players in 2016
Table United States Alzheimer's Disease Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Alzheimer's Disease Drug Product Types
Figure Alzheimer's Disease Drug Market Share of Top 3 Players
Figure Alzheimer's Disease Drug Market Share of Top 5 Players
Table United States Alzheimer's Disease Drug Sales by Type (2012-2017)
Table United States Alzheimer's Disease Drug Sales Market Share by Type (2012-2017)
Figure United States Alzheimer's Disease Drug Sales Market Share by Type 2016
Figure 2016 United States Alzheimer's Disease Drug Sales Market Share by Type
Table United States Alzheimer's Disease Drug Revenue (Million USD) by Type (2012-2017)
Table United States Alzheimer's Disease Drug Revenue Market Share by Type (2012-2017)
Figure United States Alzheimer's Disease Drug Revenue Market Share by Type 2016
Figure 2016 United States Alzheimer's Disease Drug Revenue Market Share by Type
Table United States Alzheimer's Disease Drug Price by Type (2012-2017)
Table United States Alzheimer's Disease Drug Sales by Application (2012-2017)
Table United States Alzheimer's Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Alzheimer's Disease Drug Sales Market Share by Application (2012-2017)
Figure 2016 United States Alzheimer's Disease Drug Sales Market Share by Application
Table United States Market Alzheimer's Disease Drug Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Allergan Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Alzheimer's Disease Drug Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Alzheimer's Disease Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Alzheimer's Disease Drug Market Share (2012-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daiichi Sankyo Alzheimer's Disease Drug Market Share (2012-2017)
Table Merz Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merz Pharma Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merz Pharma Alzheimer's Disease Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Alzheimer's Disease Drug Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Alzheimer's Disease Drug Market Share (2012-2017)
Table Lundbeck. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lundbeck. Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lundbeck. Alzheimer's Disease Drug Market Share (2012-2017)
Figure United States Alzheimer's Disease Drug Sales and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer's Disease Drug Revenue and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer's Disease Drug Price Trend Forecast (2017-2022)
Table United States Alzheimer's Disease Drug Sales Forecast by Type (2017-2022)
Figure United States Alzheimer's Disease Drug Sales Market Share Forecast by Type (2017-2022)
Figure United States Alzheimer's Disease Drug Sales Market Share Forecast by Type in 2022
Table United States Alzheimer's Disease Drug Sales Forecast by Application (2017-2022)
Figure United States Alzheimer's Disease Drug Sales Market Share Forecast by Application (2017-2022)
Figure United States Alzheimer's Disease Drug Sales Market Share Forecast by Application in 2022
Table Production Base and Market Concentration Rate of Raw Material
Figure Alzheimer's Disease Drug Main Raw Materials Price Trend
Table Alzheimer's Disease Drug Raw Materials Major Suppliers List
Figure Production Cost Structure of Alzheimer's Disease Drug
Figure Alzheimer's Disease Drug Manufacturing Process/Method
Figure Alzheimer's Disease Drug Value Chain Analysis
Table Raw Materials Sources of Alzheimer's Disease Drug Major Players in 2016
Table Major Buyers of Alzheimer's Disease Drug
Table Alzheimer's Disease Drug Distributors/Traders List in United States
  • Global Dementia and Movement Disorder Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 128
    Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia. Scope of the Report: This report studies the Dementia and Movement Disorder Treatment market status a......
  • Global Alzheimer's Disease Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the Alzheimer's disease partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Alzheimer's Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals ......
  • Global Dementia Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Dementia Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value......
  • Global and Chinese Nicergoline Industry, 2018 Market Research Report
    Published: 29-Sep-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Nicergoline Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Nicergoline industry with a focus on the Chinese market. The report provides key statistics on the market status of the Nicergoline manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, appli......
  • Global and Chinese Oxiracetam Industry, 2018 Market Research Report
    Published: 29-Sep-2018        Price: US 3000 Onwards        Pages: 135
    The 'Global and Chinese Oxiracetam Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Oxiracetam industry with a focus on the Chinese market. The report provides key statistics on the market status of the Oxiracetam manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applicat......
  • Global and India Alzheimer's Disease Drug Market Research by Company, Type & Application 2013-2025
    Published: 17-Aug-2018        Price: US 2000 Onwards        Pages: 106
    Summary Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Market Segment as follows: By Type - Donepezil - Memantine - Rivastigmine By Application - Early to Moderate Stages - Moderate to Severe Stages By Company - Lundbeck. -......
  • Global Alzheimer's Disease Drug Market Professional Survey Report 2018
    Published: 26-Jun-2018        Price: US 3500 Onwards        Pages: 108
    This report studies the global Alzheimer's Disease Drug market status and forecast, categorizes the global Alzheimer's Disease Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Alzheimer's Disease Drug market is valued at xx million US$ in 2017 and is expected to......
  • Global Alzheimer's Disease Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Jun-2018        Price: US 3480 Onwards        Pages: 133
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicatio......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Alzheimer's Disease Drug Market 2018, Forecast to 2023
    Published: 22-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicatio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs